SCHEMBL1786084

SCHEMBL1786084

OC1CCCC1=C1CCCC1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
UGT2B17 O75795 2/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29906669 1.00 UGT2B17 (0.32) UGT2B17KDM4EPOLBL3MBTL1
SCHEMBL1069232 0.92 KDM4E (0.35) KDM4EPOLBL3MBTL1
SCHEMBL9245201 0.90 KDM4E (0.32) KDM4EPOLBL3MBTL1
SCHEMBL1696364 0.87 KDM4E (0.31) KDM4EPOLBL3MBTL1
SCHEMBL12048397 0.84
SCHEMBL20038895 0.83 KDM4E (0.39) UGT2B17KDM4EPOLBL3MBTL1
SCHEMBL10445894 0.83 UGT2B17 (0.37) UGT2B17KDM4EPOLBL3MBTL1
SCHEMBL9883861 0.83 UGT2B17 (0.37) UGT2B17KDM4EPOLBL3MBTL1
SCHEMBL20038926 0.77
SCHEMBL10446042 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0770671-B1 Cyclopentylidene-cyclopentanol in perfumery QUEST INT (NL) 1999-09-22 EP claimed
US-5776884-A PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1998-07-07 US claimed
EP-0770671-A2 Cyclopentylidene-cyclopentanol in perfumery QUEST INTERNATIONAL B.V. (NL) 1997-05-02 EP claimed
JP-9165594-A None JP disclosed
JP-11029525-A None JP disclosed
CN-107814676-B Preparation method of decahydronaphthalene and tetrahydronaphthalene 中国科学院大连化学物理研究所 2021-12-28 CN disclosed
CN-101784509-B Cyclopropanation process GIVAUDAN SA 2013-12-18 CN disclosed
US-8450533-B2 Cyclopropanation process GIVAUDAN SA (CH) 2013-05-28 US disclosed
US-8450533-B2 Cyclopropanation process GIVAUDAN SA (CH) 2013-05-28 US disclosed
US-8450533-B2 Cyclopropanation process GIVAUDAN SA (CH) 2013-05-28 US disclosed
US-20110124924-A1 Cyclopropanation Process GIVAUDAN SA (CH) 2011-05-26 US disclosed
JP-H1129525-A NEW CYCLOPENTYL ACRYLATE COMPOUND AND ITS PRODUCTION NIPPON ZEON CO LTD 1999-02-02 JP disclosed
US-5776884-A PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1998-07-07 US disclosed
US-5776884-A PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1998-07-07 US disclosed
US-5776884-A PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 1998-07-07 US disclosed
EP-0770671-A3 Cyclopentylidene-cyclopentanol in perfumery QUEST INT (NL) 1997-09-17 EP disclosed
JP-H09165594-A CYCLOPENTYLIDENE-CYCLOPENTANOL IN PERFUME QUEST INTERNATL BV 1997-06-24 JP disclosed
EP-0770671-A2 Cyclopentylidene-cyclopentanol in perfumery QUEST INTERNATIONAL B.V. (NL) 1997-05-02 EP disclosed
EP-0770671-A2 Cyclopentylidene-cyclopentanol in perfumery QUEST INTERNATIONAL B.V. (NL) 1997-05-02 EP disclosed
EP-0770671-A2 Cyclopentylidene-cyclopentanol in perfumery QUEST INTERNATIONAL B.V. (NL) 1997-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124924-A1 Cyclopropanation Process CBR3, CYP4F3, DBF4 UGT2B17 1604/4885KDM4E 3540/4885POLB 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.